
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
Prologue is designing powerful new medicines by unlocking the viral proteome. The companys state-of-the-art DELVETM Platform systematically identifies and evaluates viral proteins and their unique features for their potential to precisely regulate human physiology. By co-opting viral evolution, Prologue is expanding the functional boundaries of proteins encoded by the human genome to create new programmable medicines. Prologue was founded by Flagship Pioneering in 2021
Prologue medicines operates in the Biotechnology research industry.
Prologue medicines's revenue is 11m - 100m
Prologue medicines has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.